Turning Biomarker Insights into Clinical Development Advantages: Earlier, Faster, Smarter

Early-stage clinical development holds enormous promise, but operational complexity often stands in the way of execution. Natera has built a fully integrated trial enablement ecosystem designed to make early-stage, biomarker-guided studies operationally feasible. From real-world data insights to commercial-to-trial enrollment pathways and end-to-end support, we help sponsors move from concept to execution with confidence.

Join us for an interactive discussion to explore how multi-timepoint molecular insights can support trial design:

• Increase probability of success and reduce risk through proactive, data-informed planning
• Engage with our team to discover how to leverage the largest US MRD commercial footprint and integrated biomarker infrastructure
• Predict response within weeks, to support dose optimization and early efficacy assessment